Stockholders' Equity - Schedule of Warrant Activity (Details) - Warrant [Member] - $ / shares |
6 Months Ended | 12 Months Ended |
|---|---|---|
Jun. 30, 2026 |
Dec. 31, 2025 |
|
| Schedule of Warrant Activity [Line Items] | ||
| Number of Warrants, Outstanding, Beginning balance | 1,139,778 | |
| Weighted Average Exercise Price, Outstanding, Beginning balance | $ 4.36 | |
| Weighted Average Remaining Life, Outstanding | 4 years 7 months 6 days | 4 years |
| Number of Shares, Granted | 4,456,550 | |
| Weighted Average Exercise Price, Granted | $ 1.47 | |
| Number of Shares, Exercised/Cancelled | ||
| Weighted Average Exercise Price, Exercised/Cancelled | ||
| Number of Warrants, Outstanding, Ending balance | 5,596,328 | 1,139,778 |
| Weighted Average Exercise Price, Outstanding,, Ending balance | $ 2.06 | $ 4.36 |
| Weighted Average Remaining Life, Granted | 4 years 9 months 18 days | |
| Weighted Average Remaining Life, Exercised/Cancelled |
| X | ||||||||||
- Definition Weighted average remaining life, exercised/cancelled. No definition available.
|
| X | ||||||||||
- Definition Number of Shares, Exercised/Cancelled. No definition available.
|
| X | ||||||||||
- Definition Weighted Average Exercise Price, Exercised/Cancelled. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining life, granted. No definition available.
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted-average contractual term remaining for option award outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|